Workflow
棒杰股份(002634) - 2019 Q1 - 季度财报
BANGJIE SHAREBANGJIE SHARE(SZ:002634)2019-04-22 16:00

Financial Performance - The company's revenue for Q1 2019 was ¥104,758,632.11, representing a 10.61% increase compared to ¥94,709,553.86 in the same period last year[7]. - Net profit attributable to shareholders decreased by 17.53% to ¥4,216,711.85 from ¥5,113,009.84 year-on-year[7]. - Total operating profit decreased by 36.79% to ¥5.22 million, primarily due to increased costs affecting gross margin[15]. - Net profit declined by 31.81% to ¥4.22 million, attributed to rising costs[15]. - The company's net profit for Q1 2019 was not explicitly stated, but the increase in retained earnings was CNY 182,763,976.02 compared to CNY 175,431,127.52 in Q1 2018, indicating a positive trend[38]. - The total profit for Q1 2019 was CNY 8,214,564.76, compared to CNY 5,691,631.18 in Q1 2018, marking a growth of 44.5%[45]. - The company's operating profit for Q1 2019 was CNY 8,207,380.21, an increase of 42.5% from CNY 5,758,340.43 in the same quarter last year[45]. - The net cash flow from operating activities was negative at -¥31,874,201.86, a decline of 32.82% compared to -¥23,998,904.74 in the previous year[7]. - The net cash flow from operating activities was -31,874,201.86 CNY, compared to -23,998,904.74 CNY in the previous period, indicating a decline in operational performance[49]. Assets and Liabilities - Total assets at the end of the reporting period were ¥906,635,373.22, down 6.73% from ¥972,043,466.54 at the end of the previous year[7]. - The total current assets as of March 31, 2019, amounted to RMB 322,714,234.95, a decrease from RMB 390,421,754.96 as of December 31, 2018[30]. - Total assets decreased to CNY 989,836,619.73 from CNY 1,026,908,295.29, a reduction of 3.6%[38]. - Total liabilities decreased to CNY 295,968,618.50 from CNY 340,373,142.56, a decline of 13.0%[38]. - Current liabilities reached CNY 283,871,983.29, while total liabilities were CNY 286,111,149.68[57]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 28,937[10]. - The largest shareholder, Tao Jianwei, holds 28.12% of the shares, with 97,237,969 shares pledged[10]. - The net assets attributable to shareholders increased by 0.61% to ¥690,149,028.71 from ¥685,932,316.86 at the end of the previous year[7]. - Shareholders' equity totaled CNY 685,932,316.86, with a capital stock of CNY 461,002,575.00[57]. Cash Flow and Investments - Cash and cash equivalents decreased by 31.92% to ¥159.18 million due to repayment of short-term loans and payments[14]. - Cash and cash equivalents decreased to CNY 93,033,998.14 from CNY 183,804,761.13, a decline of 49.3%[35]. - Cash flow from investing activities showed a net outflow of -10,922,917.25 CNY, compared to -15,515,530.87 CNY in the previous period, reflecting reduced investment losses[50]. - Cash inflow from financing activities was 50,000,000.00 CNY, an increase from 43,902,936.00 CNY in the previous period, indicating improved financing efforts[50]. - The company reported a net cash flow from financing activities of -27,889,708.98 CNY, a significant decrease from -7,274,249.73 CNY in the previous period, highlighting increased debt repayment[50]. Operational Metrics - Accounts receivable increased by 47.76% to ¥57.27 million, indicating a rise in customer payments[14]. - Prepayments rose by 64.40% to ¥6.45 million, reflecting increased payments to suppliers[14]. - Operating costs for Q1 2019 amounted to CNY 100,342,465.94, up from CNY 89,320,828.55 in the same period last year, reflecting a growth of 12.7%[39]. - The company paid 15,472,323.75 CNY in taxes, significantly higher than 2,503,405.61 CNY in the previous period, reflecting increased tax obligations[53]. Future Plans and Projects - The company plans to repurchase shares with a budget between ¥50 million and ¥100 million, with a maximum price of ¥5 per share[16]. - The company is investing in a new project to expand dyeing and finishing capacity for 7,500 tons of apparel products[17]. - The company has established a medical health investment partnership with a total fund size of ¥100 million, with a 49% contribution from one of its subsidiaries[19].